CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Alibaba
BABA
|
$2.59M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 4 |
Intel
INTC
|
$2.07M |
| 5 |
Coca-Cola
KO
|
$1.91M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SPDR S&P Biotech ETF
XBI
$5.07B
| $3.31M | 0.42% |
34,880
+25,976
| +292% | +$2.46M |
|
52
Atlassian
TEAM
$46.6B
| $3.24M | 0.41% |
16,610
+2,504
| +18% | +$489K |
|
53
Pinterest
PINS
$24.9B
| $3.23M | 0.41% |
93,119
+68,119
| +272% | +$2.36M |
|
54
Datadog
DDOG
$47.7B
| $3.2M | 0.41% |
25,879
+281
| +1% | +$34.7K |
|
55
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.2M | 0.41% |
36,621
+14,465
| +65% | +$1.26M |
|
56
Alphabet (Google) Class C
GOOG
$2.58T
| $3.08M | 0.39% |
20,249
+15,848
| +360% | +$2.41M |
|
57
SPDR Gold MiniShares Trust
GLDM
$17B
| $3M | 0.38% |
68,200
-3,500
| -5% | -$154K |
|
58
abrdn Physical Gold Shares ETF
SGOL
$5.5B
| $2.87M | 0.36% |
135,000
| – | – |
|
59
Goldman Sachs Physical Gold ETF Shares
AAAU
$1.66B
| $2.81M | 0.36% |
128,000
-10,000
| -7% | -$220K |
|
60
Ulta Beauty
ULTA
$22.1B
| $2.76M | 0.35% |
5,280
+1,893
| +56% | +$990K |
|
61
SPDR Gold Trust
GLD
$107B
| $2.74M | 0.35% |
13,300
| – | – |
|
62
iShares Gold Trust
IAU
$50.6B
| $2.73M | 0.35% |
65,000
| – | – |
|
63
Viatris
VTRS
$12.3B
| $2.73M | 0.35% |
228,272
+89,501
| +64% | +$1.07M |
|
64
Neurocrine Biosciences
NBIX
$13.8B
| $2.64M | 0.34% |
19,148
+7,784
| +68% | +$1.07M |
|
65
Royalty Pharma
RPRX
$15.6B
| $2.61M | 0.33% |
85,879
+34,207
| +66% | +$1.04M |
|
66
Sanofi
SNY
$121B
| $2.56M | 0.33% |
52,642
+20,186
| +62% | +$981K |
|
67
Intuitive Surgical
ISRG
$170B
| $2.55M | 0.32% |
6,400
+887
| +16% | +$354K |
|
68
Incyte
INCY
$16.5B
| $2.46M | 0.31% |
43,138
+17,220
| +66% | +$981K |
|
69
Lowe's Companies
LOW
$145B
| $2.42M | 0.31% |
9,509
-2,599
| -21% | -$662K |
|
70
Medpace
MEDP
$13.4B
| $2.38M | 0.3% |
5,882
+2,327
| +65% | +$940K |
|
71
Target
TGT
$43.6B
| $2.37M | 0.3% |
13,390
+4,154
| +45% | +$736K |
|
72
New Oriental
EDU
$7.85B
| $2.36M | 0.3% |
+27,235
| New | +$2.36M |
|
73
GSK
GSK
$79.9B
| $2.35M | 0.3% |
54,345
| – | – |
|
74
argenx
ARGX
$43.6B
| $2.34M | 0.3% |
5,954
+2,235
| +60% | +$880K |
|
75
Sarepta Therapeutics
SRPT
$1.78B
| $2.33M | 0.3% |
18,028
+7,204
| +67% | +$933K |
|